Drug profile

The FDA adverse-event record for Proin Er

15 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Proin Er. See the species affected, top reactions, and outcomes below.

15
adverse-event reports
40.0%
death-coded share
Dog
most-reported species
6
Lethargy (see also Central nervous system depression in Neurological) - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
15
Total Reports
6
Deaths Reported
40.0%
Death Rate

Active Ingredients

Proin Er

Administration Routes

UnknownOral

Species Affected

Dog 15

Most Affected Breeds

Retriever - Labrador 6
Crossbred Canine/dog 2
Boxer (German Boxer) 1
Shepherd Dog - German 1
Terrier (unspecified) 1
Bulldog - English 1
Mastiff (unspecified) 1
Dachshund (unspecified) 1
Mountain Cur 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in Neurological) 6
Urinary incontinence 4
Nystagmus 4
Collapse NOS (see also Cardio-vascular and Neurological disorders) 4
Death 3
Excessive thirst 3
Nausea 3
Hypersalivation 3
Not eating 3
Hind limb ataxia 3
Aspiration pneumonia 3
Emesis (multiple) 3

Outcome Breakdown

Ongoing
5 (33.3%)
Died
3 (20.0%)
Euthanized
3 (20.0%)
Recovered/Normal
2 (13.3%)
Outcome Unknown
2 (13.3%)

Proin Er Adverse Event Insights

15 reports name Proin Er; 6 recorded a death outcome (40.0% of reported events, not a population-level mortality rate). Active ingredient: Proin Er. Administration routes: Unknown, Oral.

By species: Dog (15 reports). By breed: Retriever - Labrador (6), Crossbred Canine/dog (2), Boxer (German Boxer) (1).

Leading clinical signs: Lethargy (see also Central nervous system depression in Neurological) (6), Urinary incontinence (4), Nystagmus (4), Collapse NOS (see also Cardio-vascular and Neurological disorders) (4). Outcome, 15 coded reports: Ongoing leads at 33.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.